Terumo Corporation
VC Fund
Tokyo, Japan
Terumo Corporation is a VC fund in Tokyo focused on Medical and Health Care. Terumo is a global leader in medical technology and has been committed to "Contributing to Society through Healthcare.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 17%
Last updated:
For AI agents: llms.txt
Industries Terumo Corporation invests in
Stages Terumo Corporation invests in
Countries Terumo Corporation invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Shibasaburo Kitasato
|
|||
4 more contacts available
Investment Focus
Industry
- Medical 4 (67%)
- Health Care 4 (67%)
- Medical Device 4 (67%)
- Wearables 1 (17%)
- Biotechnology 1 (17%)
Stage
- Series A 1 (17%)
- Series C 1 (17%)
- Series D 1 (17%)
- Funding Round 1 (17%)
- Post-IPO Equity 1 (17%)
Country
- United States 2 (33%)
- Japan 1 (17%)
- France 1 (17%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Shibasaburo Kitasato
Founder
|
Founder | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Orchestra BioMed
|
Orchestra BioMed, Inc. is a biomedical innovation company focused on developing high impact, high value, evidence-based therapeutic solutions for medical procedures that address major medical conditions. Its main focus is on developing new therapies for cardiovascular diseases which are the leading cause of death worldwide, taking the lives of 17.7million people each year, or 31% of all global deaths according to the World Health Organization.It was founded in 2017 and is headquartered in New Hope, Pennsylvania. | $20M / Post-IPO Equity / Oct 28, 2025 | |
Diabeloop
|
Diabeloop is a medical device company for diabetes and closed-loop system. It also develops disruptive technological innovations to automate the treatment of diabetes.The company mission is to make accessible disruptive technological innovations that will allow people with type 1 diabetes to live the life they want. Diabeloop was founded in 2015and is headquartered in Grenoble, Auvergne-Rhône-Alpes, France. | $16.3M / Venture - Series Unknown / Mar 04, 2024 | |
|
Diabeloop
|
Diabeloop is a medical device company for diabetes and closed-loop system. It also develops disruptive technological innovations to automate the treatment of diabetes.The company mission is to make accessible disruptive technological innovations that will allow people with type 1 diabetes to live the life they want. Diabeloop was founded in 2015and is headquartered in Grenoble, Auvergne-Rhône-Alpes, France. | $75.3M / Series C / Jun 02, 2022 | |
|
Orchestra BioMed
|
Orchestra BioMed, Inc. is a biomedical innovation company focused on developing high impact, high value, evidence-based therapeutic solutions for medical procedures that address major medical conditions. Its main focus is on developing new therapies for cardiovascular diseases which are the leading cause of death worldwide, taking the lives of 17.7million people each year, or 31% of all global deaths according to the World Health Organization.It was founded in 2017 and is headquartered in New Hope, Pennsylvania. | $110M / Series D / Jan 30, 2022 | |
Cuorips
|
CUORiPS is a company developing new medical care based on world's cutting-edge technology originated in Japan. | $141.7M / Jul 20, 2018 | |
ReThink Medical
|
ReThink Medical is a medical device and digital health company developing a wrist-worn monitoring device. Our technology is designed to predict and prevent heart failure hospitalizations through compliance-centric continuous physiologic monitoring & machine learning. Our product, CorBand™ uses state of the art algorithms and artificialintelligence to potentially detect worsening conditions weeks in advance - even before noticeable symptoms. Data-driven therapy can allow ample time for proper treatment to prevent hospitalization, improve quality of life, and save billions in healthcare costs. We've designed a proactive approach to managing heart failure patients with a focus on compliance, simplicity, and accuracy. | $3.5M / Series A / May 01, 2017 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Terumo Corporation invest in?
Terumo Corporation invests primarily in Medical, Health Care and Medical Device startups, most often at Series A and Series C stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Terumo Corporation?
Public channels for Terumo Corporation include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Terumo Corporation?
The team at Terumo Corporation includes Shibasaburo Kitasato (Founder). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
